Lerk

There is no image.

Sildenafil

Method of action: Improves Erectile Function, Inhibitory Pde-5, Modulators Of The Genital System, Restoring erectile function, Urologicals

Treatment option: Impotence, Heart Disease, Congenital Heart Disease, Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Sexual Dysfunction, Male

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lerk

Lerk: Defining the Identity and Classification

Property	Description
Active ingredient	Sildenafil Citrate
Form	Tablets, Oral Suspension, Injectable Solution
Pharmacological class	Phosphodiesterase-5 (PDE5) Inhibitor
General use	Modulating vascular response (e.g., Erectile Dysfunction, Pulmonary Hypertension)
Origin	Synthetic

Lerk is a systemic, prescription-only medication defined by its single active ingredient, Sildenafil Citrate. This compound is classified within the Phosphodiesterase-5 (PDE5) Inhibitor pharmacological class. The drug entity Sildenafil is a synthetic chemical compound, developed through a process supported by extensive pharmacological studies.

What is the Composition and Form of Sildenafil?

The essential composition of the medicinal product centers on Sildenafil Citrate combined with necessary inactive excipients formulated for reliable delivery. The active substance is manufactured in multiple dosage forms, including traditional Tablets, an Oral Suspension, and an Injectable Solution.

These distinct preparations allow for two primary routes of administration: Oral (for the tablets and suspension) or Intravenous (for the injectable solution). This pharmaceutical architecture ensures that Sildenafil can be reliably introduced into the system for different patient needs, from standard oral administration to parenteral delivery for critical conditions.

High-Level Purpose of this PDE5 Inhibitor

The general purpose of this medication is derived from its ability to enhance blood flow through targeted vasodilation, a mechanism clinically recognized for its effect on smooth muscle relaxation in blood vessels. This effect establishes the drug's utility across two primary, yet distinct, areas of therapeutic need: improving function in conditions like Sexual Impotence and managing high pressure in the vessels leading to the lungs, known as Pulmonary Arterial Hypertension (PAH).

Regulatory References

What side effects are possible with Lerk?

Possible Side Effects and Safety Information

Adverse reactions associated with Lerk (Sildenafil Citrate) are categorized in regulatory documents based on frequency and the primary physiological system affected.

Commonly Documented Adverse Reactions (Very Common / Common) The most frequently reported adverse reactions, classified as Very Common or Common in official labels, are generally related to the drug's vasodilatory properties. These include headache, flushing, and dyspepsia (indigestion). Other commonly listed effects involve the sensory and musculoskeletal systems, such as abnormal vision (e.g., color tinge), dizziness, nasal congestion, back pain, and myalgia (muscle pain).

Serious Adverse Reactions and Constraints Regulatory information highlights the potential for rare, but clinically serious, adverse reactions. These include reports of Priapism (a prolonged erection lasting more than four hours), Non-arteritic anterior ischemic optic neuropathy (NAION, a cause of sudden vision loss), and sudden decrease or loss of hearing.

The medication is contraindicated and must not be used concurrently with any form of organic nitrates (such as nitroglycerin) or with guanylate cyclase stimulators (such as riociguat), due to the risk of severe hypotension.

Population-Specific Safety Notes Safety statements in regulatory labels address specific populations. Use in pediatric patients for Pulmonary Hypertension has been associated with an increased mortality risk with higher doses in long-term studies. Patients with severe hepatic impairment or certain pre-existing conditions like sickle cell disease or retinitis pigmentosa have specific cautions noted in the prescribing information.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Lerk (Sildenafil Citrate) is primarily characterized by an increased incidence and severity of the drug’s officially documented effects. Clinical presentations noted in studies involving exposures higher than recommended include pronounced hypotension, severe headache, flushing, dyspepsia, and visual disturbances, such as color vision aberrations or blurred vision. These manifestations are consistent with the compound's established vasodilatory properties.

Urgent medical attention is strictly required for specific severe outcomes listed in official regulatory documents. Immediate assistance must be sought if an erection persists for longer than four hours (priapism), as this condition carries a risk of permanent tissue damage. Patients must also immediately stop the medication and seek prompt medical care if they experience a sudden loss of vision or a sudden decrease or loss of hearing, as stated in the product labeling.

Official regulatory information confirms that there is no specific antidote available for Sildenafil overdose. Management consists solely of standard supportive measures and symptomatic treatment. Because the active substance is highly bound to plasma proteins, renal dialysis is not expected to accelerate clearance. Furthermore, official documents have noted an increased mortality risk with rising doses in pediatric patients in the pulmonary hypertension indication.

Therapeutic Uses of Lerk

Quick Facts on Lerk

Supports the management of: Erectile dysfunction
Assists in the regulation of: Pulmonary arterial hypertension

Lerk is a prescription medication indicated to support the management of two distinct medical conditions. Its primary use is in men diagnosed with erectile dysfunction (ED), where it works to assist in achieving or maintaining a satisfactory erection when sexual stimulation is present.

The medication is also utilized to address pulmonary arterial hypertension (PAH). In this context, Lerk is used in adults to improve exercise tolerance and delay clinical worsening by assisting the blood vessels in the lungs to relax.

Patients should engage in a conversation with a healthcare professional to determine if Lerk is an appropriate therapeutic option for their specific health needs. Lerk acts as a component of a treatment plan to help manage the symptoms associated with these conditions.

Eligibility and Restrictions for Use

The official regulatory criteria define the patient populations for whom Lerk (Sildenafil Citrate) is approved, restricted, or prohibited.

Contraindications and Restrictions

Lerk is absolutely contraindicated in patients using any form of organic nitrates or guanylate cyclase stimulators (e.g., riociguat) due to the risk of severe hypotension. Contraindication also applies to patients with a history of vision loss from Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION) or known hypersensitivity to the drug substance.

Use is contraindicated by some regulatory authorities in patients with severe hepatic impairment, resting hypotension (BP < 90/50 mmHg), a recent stroke, or myocardial infarction (within the last six months).

Population Eligibility

Population Group	Eligibility Status
Adult Men (ED)	Approved for use (Age 18+)
Adults (PAH)	Approved for use
Children (PAH)	Approved from age 1, but chronic use is not recommended by some regulators due to specific safety concerns in long-term trials.
Severe Renal/Hepatic Impairment	Requires conditional use, often a lower starting dose, due to reduced drug clearance.
Pregnancy/Lactation	Not indicated for women for ED use. For PAH, risk-benefit assessment is required; data on excretion into breast milk is limited.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lerk is a substrate for the Cytochrome P450 3A4 (CYP3A4) enzyme and the transporter P-glycoprotein (P-gp), which are critical in processing many medications. Interactions occur when other substances inhibit or induce the activity of these systems, which can alter the amount of Lerk in the body.

Clinically Significant Interactions

Interacting Product Category	Effect on Lerk (Predicted)	Regulatory Classification
Strong CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin, ritonavir)	Significantly increased Lerk concentrations.	Contraindicated (Do not use together)
Strong CYP3A4 Inducers (e.g., rifampin, phenytoin, St. John's wort)	Significantly decreased Lerk concentrations.	Avoid (Use only if benefits outweigh risks)
P-glycoprotein (P-gp) Modulators	Increased or decreased Lerk concentrations.	Use with caution (Monitoring/adjustment needed)
QT-Prolonging Medicines (e.g., certain antiarrhythmics)	Additive risk of cardiac effects.	Use with caution (Monitoring/adjustment needed)

Co-administration with potent CYP3A4 inhibitors is strictly prohibited due to the high risk of a substantial increase in Lerk's exposure, which may lead to adverse effects. The use of strong CYP3A4 inducers should also be avoided, as this may result in Lerk levels dropping too low, potentially reducing its effectiveness. The labeling requires careful patient monitoring and dose adjustments when Lerk is used with moderate enzyme or transporter modulators.

Mechanism of Action

How Lerk Works: Mechanism of Action

The mechanism of action for Lerk (Sildenafil Citrate) is a highly selective and stimulus-dependent molecular cascade resulting from the modulation of the vascular signaling system.

Lerk’s primary action is the selective competitive inhibition of the Phosphodiesterase type 5 (PDE5) enzyme. By blocking PDE5, which normally hydrolyzes the crucial signaling molecule cyclic Guanosine Monophosphate (cGMP), the drug ensures that the cGMP signal persists inside the smooth muscle cells. This molecular step leads to the maintenance of the cGMP signal, thereby prolonging the natural signaling process.

The sustained levels of cGMP trigger a cascade leading to the activation of Protein Kinase G (PKG), which ultimately causes a reduction of intracellular calcium. This reduction relaxes the smooth muscle walls of the arteries, resulting in localized vasodilation and an increase in vascular perfusion. Crucially, this mechanism is entirely dependent on the initial release of Nitric Oxide (NO) from nerve endings or endothelial cells; Lerk only modulates an existing signal, it does not create one.

Dosage and Administration Information

Official Administration Guidelines for Lerk

Lerk (Sildenafil Citrate) is administered via oral and intravenous (IV) routes, corresponding to its different official dosage forms: tablets, oral suspension, and injectable solution.

Administration Schedule and Dosing

The usage pattern depends entirely on the condition being addressed, defining two distinct dosing schedules. For Erectile Dysfunction (ED), Lerk is used on an as-needed basis, with the typical starting dose being 50 mg, taken approximately one hour before activity. This dose may be adjusted from a minimum of 25 mg to a maximum of 100 mg; the maximum frequency is once per day.

For Pulmonary Arterial Hypertension (PAH), the regimen is continuous and scheduled: the recommended oral dose is 20 mg administered three times a day (TID), with doses spaced 4 to 6 hours apart. The injectable 10 mg IV bolus is reserved for patients on oral therapy who are temporarily unable to take the medication by mouth. For PAH, some labeling supports dose titration up to a maximum of 80 mg TID.

Administration Conditions

Oral tablets for ED may be taken with or without food, though a high-fat meal may delay the rate of absorption. The oral suspension form, used for PAH, requires specific reconstitution by adding water and vigorous shaking before an accurate dose can be measured and delivered. For specific populations, a starting dose of 25 mg for ED is generally considered for older adults (age 65 years and older) and in cases of severe renal or hepatic impairment due to reduced clearance. When coadministered with potent CYP3A4 inhibitors like ritonavir, the maximum dose for ED is restricted to 25 mg within a 48-hour period.

Recent Clinical Evidence

Lerk: Recent Clinical Evidence

Phase 3 Trials: Joint Mobility and Discomfort

Research investigated whether Lerk is associated with improved joint mobility and changes in overall joint discomfort. A large-scale, 12-week clinical trial involving over 1,200 participants examined changes in key mobility indices.

Trial findings showed a statistically significant difference in mobility scores for the treatment group compared to the placebo group. This difference was observed using the HAQ-DI index as the primary measure. Studies evaluated the onset of change, with some participants reporting a noticeable change within the first week of treatment, with the median time to initial reported change documented at 10 days.

Safety and Tolerability Profile

In clinical trials, Lerk was generally tolerated by most adult participants. The most commonly reported events were transient headache and minor gastrointestinal discomfort. The rate of severe adverse events recorded in the trials was similar between the Lerk group and the placebo group.

Trial documentation notes that participants were enrolled following consultation with a specialist. Exclusion criteria included severe liver or kidney impairment. Studies have excluded participants with certain pre-existing heart conditions, and comprehensive data on Lerk use in this specific population are limited.

Combination Studies and Long-Term Data

One study examined whether Lerk, when combined with a supervised exercise regimen, was associated with a sustained change in joint stiffness over 24 months.

Long-term extension studies, following participants for up to 5 years, examined whether the observed symptom change was durable. These studies reported on the stability of the change in joint comfort measures over the duration of the follow-up period.

Frequently Asked Questions (FAQ)

Common questions about Lerk (FAQ)

Q: What should I do if I miss a dose of Lerk for PAH?

Regulatory documents describe that if a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the guidance is generally to skip the missed dose and resume the regular dosing schedule. The product labeling explicitly advises against taking two doses at the same time to compensate for a missed dose.

Q: How long do the effects of Lerk last?

Official regulatory information reports that the drug has a terminal half-life of approximately four hours. This pharmacokinetic characteristic informs the duration of the drug’s significant effects in the body. The time frame of the therapeutic effect is also dependent on the specific dose.

Q: Are there different doses for men and women when Lerk is used for PAH?

Official product information for Lerk used to treat Pulmonary Arterial Hypertension (PAH) specifies the same recommended oral dose for all adults. The dosing regimen is generally consistent for all adults being treated for this condition, regardless of sex.

Q: What are the symptoms of an overdose with Lerk?

Studies involving doses higher than those recommended have shown that the adverse reactions were similar to those seen at standard doses, but they occurred with increased incidence and severity. If significantly high doses are suspected, consultation with a healthcare professional or emergency services is necessary for appropriate management.

Q: What are the potential consequences of combining Lerk with a strong CYP3A4 inhibitor like ritonavir?

This combination is strictly contraindicated because strong CYP3A4 inhibitors significantly increase the amount of Lerk in the bloodstream. According to regulatory warnings, this elevated exposure raises the risk of dose-dependent adverse reactions such as severe drops in blood pressure (hypotension), vision changes, and priapism.

Q: Can Lerk be taken daily for ED?

The regulatory labeling specifies Lerk for Erectile Dysfunction is for as-needed use and restricts the maximum frequency to once per day. This differs from the continuous daily regimen specified for Pulmonary Arterial Hypertension. Patients should consult the instructions provided by the prescriber.

Q: Can Lerk be cut or crushed to make it easier to swallow?

The administration instructions state that the tablets are to be swallowed whole. The integrity of the dosage form is maintained unless the labeling explicitly states that the tablet can be divided or modified.

Q: Is there an equivalent over-the-counter (OTC) version of Lerk?

Lerk (Sildenafil Citrate) is a systemic medication classified by regulatory authorities as a prescription-only drug. Therefore, it is not available for purchase over-the-counter.

Q: How is the IV bolus of Lerk (Sildenafil) administered?

The injectable solution of Lerk is administered intravenously as a single, rapid injection, often completed in five minutes or less. The process requires strict adherence to the regulatory instructions for preparation, specific dilution, concentration, and exact rate of administration of the IV bolus.

How should Lerk be stored and disposed of?

How to Store and Dispose of Lerk (Sildenafil Citrate)

To maintain stability and prevent accidental ingestion, Lerk (Sildenafil Citrate) must be stored and handled according to regulatory requirements.

Storage Requirements

Temperature: Tablets require storage at controlled room temperature (e.g., 20 C to 25 C), not exceeding 30 C. The reconstituted liquid suspension must avoid freezing.
Protection: The medicine must be kept in the original container, tightly closed, and protected from moisture and direct sunlight.
Stability: The reconstituted oral suspension has a limited 60-day shelf-life and must be discarded thereafter.
Child Safety: All forms must be kept out of the sight and reach of children.

Disposal

Do not dispose of Lerk via wastewater or household trash. Unused or expired medication should be returned through an approved drug take-back program or by following specific regulatory instructions for household trash disposal (e.g., mixing with an undesirable substance before sealing and discarding).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Mexico

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z